Market Access The critical importance of payer-provider collaboration goes... The critical need to improve prior authorisation processes might have reached its tipping point on the 17th January.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
